Detalhe da pesquisa
1.
Care of Late-Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries.
Mov Disord
; 39(3): 571-584, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38425158
2.
Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease.
Eur J Neurol
; 31(2): e16144, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37955562
3.
The Care Needs of Patients With Cognitive Impairment in Late-Stage Parkinson's Disease.
J Geriatr Psychiatry Neurol
; : 8919887231225484, 2024 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38230692
4.
Factors associated with self-rated health in people with late-stage parkinson's and cognitive impairment.
Qual Life Res
; 2024 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38888672
5.
A systematic practice review: Providing palliative care for people with Parkinson's disease and their caregivers.
Palliat Med
; 38(1): 57-68, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38054428
6.
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals.
Mov Disord
; 38(7): 1236-1252, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37147135
7.
Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson's disease: clinical and therapeutic considerations.
J Neural Transm (Vienna)
; 130(11): 1451-1462, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37603058
8.
A Paradigm Shift in the Management of Patients with Parkinson's Disease.
Neurodegener Dis
; 23(1-2): 13-19, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37913759
9.
Meaning in Life in Late-Stage Parkinson's Disease: Results from the Care of Late-Stage Parkinsonism Study (CLaSP) in Six European Countries.
J Relig Health
; 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38049708
10.
Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial.
BMC Neurol
; 22(1): 88, 2022 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35279112
11.
Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries.
BMC Neurol
; 22(1): 35, 2022 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35073872
12.
Caregiver Burden in Late-Stage Parkinsonism and Its Associations.
J Geriatr Psychiatry Neurol
; 35(1): 110-120, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33094677
13.
Quality of life and resource utilization-Swedish data from the Care of Late-Stage Parkinsonism (CLaSP) study.
Acta Neurol Scand
; 145(6): 743-752, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35312034
14.
Parkinson's disease in Sweden-resource use and costs by severity.
Acta Neurol Scand
; 144(5): 592-599, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34254292
15.
Swedish guidelines for device-aided therapies in Parkinson's disease -Economic evaluation and implementation.
Acta Neurol Scand
; 144(2): 170-178, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33899213
16.
The Non-Motor Symptoms Scale in Parkinson's disease: Validation and use.
Acta Neurol Scand
; 143(1): 3-12, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32813911
17.
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia.
Mov Disord
; 35(6): 1046-1054, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32198802
18.
Levodopa infusion in Parkinson's disease: Individual quality of life.
Acta Neurol Scand
; 142(3): 248-254, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32383152
19.
Everyday Occupations and Other Factors in Relation to Mental Well-Being among Persons with Advanced Parkinson's Disease.
Occup Ther Health Care
; 34(1): 1-18, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31766928
20.
EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
Mov Disord
; 34(3): 353-365, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30719763